These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of mechanical assist during high-risk PCI and STEMI with cardiogenic shock. Cyrus T; Mathews SJ; Lasala JM Catheter Cardiovasc Interv; 2010 Mar; 75 Suppl 1():S1-6. PubMed ID: 20333708 [TBL] [Abstract][Full Text] [Related]
3. Cardiogenic shock secondary to severe acute ischemic mitral regurgitation managed with an Impella 2.5 percutaneous left ventricular assist device. Harmon L; Boccalandro F Catheter Cardiovasc Interv; 2012 Jun; 79(7):1129-34. PubMed ID: 21805597 [TBL] [Abstract][Full Text] [Related]
4. Clinical use of temporary percutaneous left ventricular assist devices. Froesch P; Martinelli M; Meier P; Cook S; Hullin R; Windecker S; Mohacsi P; Meier B Catheter Cardiovasc Interv; 2011 Aug; 78(2):304-13. PubMed ID: 21766420 [TBL] [Abstract][Full Text] [Related]
5. New percutaneous mechanical left ventricular support for acute MI: the AMC MACH program. Henriques JP; de Mol BA Nat Clin Pract Cardiovasc Med; 2008 Feb; 5(2):62-3. PubMed ID: 18043597 [No Abstract] [Full Text] [Related]
6. Mechanical versus pharmacologic support for cardiogenic shock. Dhar G; Jolly N Catheter Cardiovasc Interv; 2010 Mar; 75(4):626-9. PubMed ID: 20049971 [TBL] [Abstract][Full Text] [Related]
7. Percutaneous life support: is it safe to plug and play? Nee LM; Lopez JJ; Nanjundappa A; Dieter RS J Invasive Cardiol; 2011 Apr; 23(4):148. PubMed ID: 21474847 [No Abstract] [Full Text] [Related]
8. Efficacy and safety of percutaneous life support during high-risk percutaneous coronary intervention, refractory cardiogenic shock and in-laboratory cardiopulmonary arrest. Bagai J; Webb D; Kasasbeh E; Crenshaw M; Salloum J; Chen J; Zhao D J Invasive Cardiol; 2011 Apr; 23(4):141-7. PubMed ID: 21474846 [TBL] [Abstract][Full Text] [Related]
9. Preliminary experience with Impella Recover(®) LP5.0 in nine patients with cardiogenic shock: a new circulatory support system in the intensive cardiac care unit. Bresson D; Sibellas F; Farhat F; Jegaden O; Kirkorian G; Bonnefoy E Arch Cardiovasc Dis; 2011 Aug; 104(8-9):458-64. PubMed ID: 21944148 [TBL] [Abstract][Full Text] [Related]
10. First experience with implantation of a percutaneous right ventricular Impella right side percutaneous support device as a bridge to recovery in acute right ventricular infarction complicated by cardiogenic shock in the United States. Margey R; Chamakura S; Siddiqi S; Senapathi M; Schilling J; Fram D; Hirst J; Saddiq I; Silverman D; Kiernan F Circ Cardiovasc Interv; 2013 Jun; 6(3):e37-8. PubMed ID: 23780299 [No Abstract] [Full Text] [Related]
11. A stepwise progression in the treatment of cardiogenic shock. Pollack A; Uriel N; George I; Kodali S; Takayama H; Naka Y; Jorde U Heart Lung; 2012; 41(5):500-4. PubMed ID: 22608034 [TBL] [Abstract][Full Text] [Related]
12. The Impella ventricular assist device: use in patients at high risk for coronary interventions: successful multivessel percutaneous coronary intervention in a 62-year-old high-risk patient. Marella PC; Lassetter JE; Heuser RR Cardiovasc Revasc Med; 2011; 12(1):69.e9-12. PubMed ID: 21036108 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous left ventricular assist device in acute myocardial infarction and cardiogenic shock. Merhi W; Dixon SR; O'Neill WW; Hanzel GS; McCullough PA Rev Cardiovasc Med; 2005; 6(2):118-23. PubMed ID: 15976733 [TBL] [Abstract][Full Text] [Related]
14. Cardiogenic shock complicating myocardial infarction and outcome following percutaneous coronary intervention. Lee KW; Norell MS Acute Card Care; 2008; 10(3):131-43. PubMed ID: 18972627 [TBL] [Abstract][Full Text] [Related]
15. Acute myocardial infarction and cardiogenic shock: pharmacologic and mechanical hemodynamic support pathways. Graf T; Desch S; Eitel I; Thiele H Coron Artery Dis; 2015 Sep; 26(6):535-44. PubMed ID: 25968304 [TBL] [Abstract][Full Text] [Related]
16. The use of percutaneous left ventricular assist device in high-risk percutaneous coronary intervention and cardiogenic shock. Akhondi AB; Lee MS Rev Cardiovasc Med; 2013; 14(2-4):e144-9. PubMed ID: 24448256 [TBL] [Abstract][Full Text] [Related]
17. Acute ventricular septal defect treated with an Impella recovery as a 'bridge therapy' to heart transplantation. Patanè F; Zingarelli E; Sansone F; Rinaldi M Interact Cardiovasc Thorac Surg; 2007 Dec; 6(6):818-9. PubMed ID: 17704122 [TBL] [Abstract][Full Text] [Related]